Life science companies are challenged more than ever to be innovative and bring better drugs to market faster, communicate more effectively with physicians and patients, and make drugs readily available to more people around the world. The industry can succeed in meeting these challenges if it takes advantage of advances in collaboration technologies in clinical trials, in the field, on the manufacturing floor, and in working with partners.